COMPARISON OF DIAGNOSTIC METHODS FOR CHRONIC KIDNEY DISEASE IN DIABETIC PATIENTS: A COMMUNITY-BASED STUDY
Main Article Content
Abstract
Background: Early detection and treatment of chronic kidney disease (CKD) in diabetic patients are crucial, as several modifiable factors can prevent or slow disease progression. However, no studies in Vietnam have compared the effectiveness of different diagnostic methods in the community setting. Objectives: To compare the effectiveness of different diagnostic methods for CKD in diabetic patients in Can Tho, Vietnam. Materials and methods: A cross-sectional analytical study conducted on 791 residents of Can Tho City with a prior diagnosis of diabetes mellitus (DM) from January 2023 to September 2023. Results: Among the study participants, the mean age was 63.5 ± 10.1 years, with a female-to-male ratio of approximately 2:1. The prevalence of CKD was 19.2%. Diagnosis based on estimated glomerular filtration rate (eGFR) using creatinine (single measurement) had a specificity of 83.3%, a negative predictive value (NPV) of 98.9%, a sensitivity of 78.1%, and a low area under the curve (AUC) of 0.577 (95% CI: 0.522–0.631). Diagnosis based on urine albumin-to-creatinine ratio (ACR) abnormalities (single measurement) had a high specificity of 98.3%, an NPV of 90.1%, and an excellent AUC of 0.918 (95% CI: 0.891–0.944), but a lower sensitivity of 69.3%. Diagnosis combining both ACR and eGFR abnormalities (single measurement) had a specificity of 82.3%, an NPV of 82.3%, a sensitivity of 83.3%, and a low AUC of 0.547 (95% CI: 0.494–0.600). Conclusion: A single urinary ACR test for CKD screening in community demonstrated a high effectiveness for ruling out CKD in diabetic patients.
Article Details
Keywords
Chronic kidney disease (CKD), diabetes mellitus (DM), estimated glomerular filtration rate (eGFR), albumin-to-creatinine ratio (ACR)
References

2. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet.2020;395(10225):709-733. Doi: 10.1016/ s0140-6736(20)30045-3.

3. Le HT, Le TT, Tran NMT, et al. Serum Uric Acid Levels and Risk of Rapid Decline of Estimated Glomerular Filtration Rate in Patients with Type 2 Diabetes: Findings from a 5-Year Prospective Cohort Study. Healthcare (Basel).2021;9(10). Doi: 10.3390/healthcare9101341.

4. Rossing P, Caramori ML, Chan JCN, et al. Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. Kidney International.2022;102(5):990-999. Doi: 10.1016/j.kint.2022.06.013.

5. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int.2022;102(5s):S1-s127. Doi: 10.1016/ j.kint.2022.06.008.

6. de Boer IH, Khunti K, Sadusky T, et al. Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care.2022; 45(12):3075-3090. Doi: 10.2337/dci22-0027.

7. Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet.2017; 389(10075): 1238-1252. Doi: 10.1016/s0140-6736(16)32064-5.

8. Hirst JA, Montes MDV, Taylor CJ, et al. Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care. Br J Gen Pract. 2018;68(673):e524-e530. Doi: 10. 3399/bjgp18X697937.

9. Naresh CN, Hayen A, Weening A, Craig JC, Chadban SJ. Day-to-day variability in spot urine albumin-creatinine ratio. Am J Kidney Dis.2013; 62(6):1095-101. Doi: 10.1053/j.ajkd.2013.06.016.
